Literature DB >> 19364854

Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Georgina A Holloway1, William N Charman, Alan H Fairlamb, Reto Brun, Marcel Kaiser, Edmund Kostewicz, Patrizia M Novello, John P Parisot, John Richardson, Ian P Street, Keith G Watson, Jonathan B Baell.   

Abstract

High-throughput screening of 100,000 lead-like compounds led to the identification of nine novel chemical classes of trypanothione reductase (TR) inhibitors worthy of further investigation. Hits from five of these chemical classes have been developed further through different combinations of preliminary structure-activity relationship rate probing and assessment of antiparasitic activity, cytotoxicity, and chemical and in vitro metabolic properties. This has led to the identification of novel TR inhibitor chemotypes that are drug-like and display antiparasitic activity. For one class, a series of analogues have displayed a correlation between TR inhibition and antiparasitic activity. This paper explores the process of identifying, investigating, and evaluating a series of hits from a high-throughput screening campaign.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364854      PMCID: PMC2704697          DOI: 10.1128/AAC.01568-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  50 in total

Review 1.  Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.

Authors:  K A Werbovetz
Journal:  Curr Med Chem       Date:  2000-08       Impact factor: 4.530

2.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

3.  Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.

Authors:  Lucía Otero; Marisol Vieites; Lucía Boiani; Ana Denicola; Carolina Rigol; Lucía Opazo; Claudio Olea-Azar; Juan Diego Maya; Antonio Morello; R Luise Krauth-Siegel; Oscar E Piro; Eduardo Castellano; Mercedes González; Dinorah Gambino; Hugo Cerecetto
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

Review 4.  Development of miltefosine for the leishmaniases.

Authors:  J D Berman
Journal:  Mini Rev Med Chem       Date:  2006-02       Impact factor: 3.862

5.  New culture medium for maintenance of tsetse tissues and growth of trypanosomatids.

Authors:  I Cunningham
Journal:  J Protozool       Date:  1977-05

6.  The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution.

Authors:  Y Zhang; C S Bond; S Bailey; M L Cunningham; A H Fairlamb; W N Hunter
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

7.  Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.

Authors:  Seheli Parveen; Mohammed O F Khan; Susan E Austin; Simon L Croft; Vanessa Yardley; Peter Rock; Kenneth T Douglas
Journal:  J Med Chem       Date:  2005-12-15       Impact factor: 7.446

8.  Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus.

Authors:  J Tovar; S Wilkinson; J C Mottram; A H Fairlamb
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

9.  Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.

Authors:  Susan Wyllie; Mark L Cunningham; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

10.  Quinazolines as adenosine receptor antagonists: SAR and selectivity for A2B receptors.

Authors:  Thomas R Webb; Dmitriy Lvovskiy; Soon Ai Kim; Xiao duo Ji; Neli Melman; Joel Linden; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2003-01-02       Impact factor: 3.641

View more
  13 in total

1.  High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin.

Authors:  Florian Fueller; Britta Jehle; Kerstin Putzker; Joe D Lewis; R Luise Krauth-Siegel
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 2.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by high-throughput screening of small-molecule chemical library.

Authors:  Kurt Lackovic; John P Parisot; Nerida Sleebs; Jonathan B Baell; Laurent Debien; Keith G Watson; Joan M Curtis; Emanuela Handman; Ian P Street; Lukasz Kedzierski
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

4.  2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.

Authors:  Matthew G LaPorte; Dimas José da Paz Lima; Feng Zhang; Malabika Sen; Jennifer R Grandis; Daniel Camarco; Yun Hua; Paul A Johnston; John S Lazo; Lynn O Resnick; Peter Wipf; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2014-09-15       Impact factor: 2.823

5.  Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.

Authors:  Erika van den Bogaart; Gerard J Schoone; Paul England; Dorien Faber; Kristina M Orrling; Jean-Claude Dujardin; Shyam Sundar; Henk D F H Schallig; Emily R Adams
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

6.  Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.

Authors:  Stephen Patterson; Magnus S Alphey; Deuan C Jones; Emma J Shanks; Ian P Street; Julie A Frearson; Paul G Wyatt; Ian H Gilbert; Alan H Fairlamb
Journal:  J Med Chem       Date:  2011-09-01       Impact factor: 7.446

7.  Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.

Authors:  Edézio Ferreira Cunha-Júnior; Valter Viana Andrade-Neto; Marta Lopes Lima; Thais Alves da Costa-Silva; Andres J Galisteo Junior; Maria A Abengózar; Coral Barbas; Luis Rivas; Elmo Eduardo Almeida-Amaral; Andre Gustavo Tempone; Eduardo Caio Torres-Santos
Journal:  PLoS Negl Trop Dis       Date:  2017-01-03

8.  Essential multimeric enzymes in kinetoplastid parasites: A host of potentially druggable protein-protein interactions.

Authors:  Leah M Wachsmuth; Meredith G Johnson; Jason Gavenonis
Journal:  PLoS Negl Trop Dis       Date:  2017-06-29

9.  A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.

Authors:  Melissa L Sykes; Vicky M Avery
Journal:  Parasit Vectors       Date:  2009-11-12       Impact factor: 3.876

10.  Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.

Authors:  Deuan C Jones; Antonio Ariza; Wing-Huen A Chow; Sandra L Oza; Alan H Fairlamb
Journal:  Mol Biochem Parasitol       Date:  2009-09-10       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.